"Expanding knowledge and access to
emergency contraception in Europe"
"Expanding knowledge and access to emergency contraception in Europe"
ECEC has recently become aware of two great videos that detail EC’s mode of action. The first one, released by HRA Pharma this year, can be found here. The second one, which was released by the Royal Women’s Hospital in Australia and is designed to reach adolescents and girls, can be found here. Both of these videos provide great information about EC in an easy-to-understand, relatable way.
November 2020. A study investigating timing of combined oral contraceptive pill (COC) restart after missed pills and use of ulipristal acetate emergency contraception (UPA EC), was recently published. According to the study (Banh C, Rautenberg T, Duijkers IJ, et al. The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing…
August 2020. In Australia, the Women’s Sexual and Reproductive Health COVID-19 Coalition just published the consensus statement on the provision of emergency contraception, which includes recommendations for primary care, pharmacy and policy. Some of the recommendations are: For primary care: Women should be advised of all available emergency contraception (EC) methods at the point of contact. Interdisciplinary collaborations and…
The UK organisation BPAS, launched a campaign that calls on pharmacies to reduce the cost of EC pills. As stated in ECEC´s last update on access to EC in Europe, the prices for both LNG and UPA EC pills when procured directly at the pharmacy in certain regions of the United Kingdom and in Ireland, are the higher in…
November 2020. The Spanish Society for Contraception (SEC) just published the findings of its annual National Contraception Survey 2020, based on phone interviews conducted among 1800 women of reproductive age, between July and August 2020. With regards to emergency contraception (EC) use, 38% of the women surveyed reported having ever used EC at some point…
April 2019. We recently updated our Publications page to include resources from colleague organizations, focused on reproductive rights and access to contraception in Europe. This valuable references, which may be of use for your work promoting EC access in our region, can be found here: European Parliament Resolution: Experiencing backlash in women’s rights and gender…
The European label for the EC product Norlevo has been updated with two major changes. In keeping with current evidence, the new label now says that LNG EC works by interfering with ovulation, and the language about the possibility that LNG EC might prevent implantation of a fertilized egg has been removed. The second change…
Menú
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy
